220 Targets. Zero Antibodies. One AI Platform.
One-third of all FDA-approved drugs target GPCRs, but almost no antibodies do. Antiverse's AI platform is changing that — and the CF Foundation just signed on.
Category Voyager Articles
CRISPR Just Became an Antibiotic. Sort Of.
SNIPR Biome publishes first clinical proof that CRISPR-engineered phages can selectively kill bacteria in the human gut.